208
Views
25
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Regioselective synthesis of feruloylated glycosides using the feruloyl esterases expressed in selected commercial multi-enzymatic preparations as biocatalysts

, &
Pages 235-244 | Received 09 Jan 2010, Accepted 11 May 2010, Published online: 01 Jul 2010
 

Abstract

Twenty multi-enzymatic preparations were evaluated for their levels of feruloyl esterase activity and their substrate specificity using methyl ferulate and isolated feruloylated non-digestible oligosaccharides from sugar-beet pulp and wheat bran as substrates. The efficiency of feruloyl esterases expressed in the six best multi-enzymatic preparations from Bacillus spp. (Ceremix), Humicola insolens (Depol 740), Aspergillus oryzae (Flavourzyme), Bacillus amyloliquefaciens (Multifect P 3000), Bacillus subtilis (RP-1) and Trichoderma reesei (Depol 670) for the synthesis of feruloylated glycosides was investigated using a surfactant-less organic microemulsion system as reaction medium. Using n-hexane, 1-butanol and MES (3-(N-morpholino)ethanesulfonic acid)–NaOH buffer reaction mixture (51:46:3 v/v/v), feruloyl esterases expressed in Multifect P 3000 resulted in the highest bioconversion yield of feruloylated arabinose (37%), whereas those present in Depol 670 led to the highest bioconversion yield of feruloylated galactose (61%). The highest bioconversion yield of feruloylated xylose (37%) was obtained using the feruloyl esterase of Depol 670 as biocatalyst in n-hexane, 2-butanone and MES–NaOH buffer reaction mixture (51:46:3 v/v/v). Feruloylated arabinose, galactose and xylose demonstrated potential antioxidant properties as indicated by their profound radical scavenging activity. The chemical structure of the feruloylated glycosides was confirmed by APCI-MS.

Declaration of interest: This project was supported by funds from McGill University and Canadian Foundation for Innovation (CFI). The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.